FOLFIRI plus cetuximab in patients with liver-limited or non-liver-limited RAS wild-type metastatic colorectal cancer: A retrospective subgroup analysis of the CRYSTAL study

Published 2016 View Full Article

Authors

Keywords

Cetuximab, CRYSTAL, LLD, R0 resection, RAS, mCRC

Journal

EJSO

Volume 42, Issue 10, Pages 1540-1547

Publisher

Elsevier BV

Online

2016-06-24

DOI

10.1016/j.ejso.2016.05.038

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started